ArticleMolecular and clinical oncology2024

Exploring predictive molecules of acute adverse events in response to volumetric‑modulated arc therapy for prostate cancer using urinary metabolites.

Hideki Obara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.